Diabetic retinopathy treatment trials: A review

International Ophthalmology Clinics

Volumn 38, Issue 2, 1998, Pages 123-154

  Arango, Jorge L ^a   Pavan, Peter Reed ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT;

DIABETES CONTROL; DIABETIC RETINOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; LASER COAGULATION; PRIORITY JOURNAL; RETINA MACULA EDEMA; REVIEW; RISK FACTOR; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; WEIGHT GAIN;

EID: 0031846734     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199838020-00010     Document Type: Review

References (57)

1. Duke-Elder S, ed. System of ophthalmology, vol 10. St Louis: Mosby, 1967:410
2. National Society to Prevent Blindness. Vision problems in the U.S. Data analysis, definitions, data sources, detailed data tables, analyses, interpretation. New York: National Society to Prevent Blindness, 1980
3. Klein R, Klein BEK, Moss SE. The epidemiology of ocular problems in diabetes mellitus. In: Feman SS, ed. Ocular problems in diabetes mellitus. Boston: Blackwell, 1991:1-51
4. Ederer F, Hiller R. Clinical trials, diabetic retinopathy and photocoagulation, a reanalysis of five studies. Surv Ophthalmol 1975;19:267
5. Goldberg MF, Fine SL, eds. Symposium on the treatment of diabetic retinopathy [Public Health Service pub. no. 1890]. Washington, DC: US Government Printing Office, 1969
6. Diabetic Retinopathy Study Group. Preliminary report on effects of photocoagulation therapy [Diabetic Retinopathy Study rep. no. 1]. Am J Ophthalmol 1976;81:383-396
7. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy. [Diabetic Retinopathy Study rep. no. 2]. Ophthalmology 1978;85:82-106
8. Diabetic Retinopathy Study Group. Four risk factors for severe visual loss in diabetic retinopathy [Diabetic Retinopathy Study rep. no. 3]. Arch Ophthalmol 1979;97:654-655
9. Diabetic Retinopathy Study Group. A short report of long-range results [Diabetic Retinopathy Study rep. no. 4]. Proceedings of the Tenth Congress of International Diabetes Federation. New York: Excerpta Medica, 1980
10. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy. Relationship of adverse treatment effects to retinopathy severity [Diabetic Retinopathy Study rep. no. 5]. Dev Ophthalmol 1981;2:1-15
11. Diabetic Retinopathy Study Group. Design, methods, and baseline results [Diabetic Retinopathy Study rep. no. 6]. Invest Ophthalmol Vis Sci 1981;21:149-209
12. Diabetic Retinopathy Study Group. A modification of the Airlie House classification of diabetic retinopathy [Diabetic Retinopathy Study rep. no. 7]. Invest Ophthalmol Vis Sci. 1981;21:210-226
13. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings [Diabetic Retinopathy Study rep. no. 8]. Ophthalmology 1981;88:583-600
14. Diabetic Retinopathy Study Group. Assessing possible late treatment effects in stopping clinical trials early: a case study by F. Ederer, MJ Podgor [Diabetic Retinopathy Study rep. no. 9]. Controlled Clin Trials 1984;5:373-381
15. Diabetic Retinopathy Study Group. Factors influencing the development of visual loss in advanced diabetic retinopathy [Diabetic Retinopathy Study rep. no. 10]. Invest Ophthalmol Vis Sci 1985;26:983-991
16. Diabetic Retinopathy Study Group. Intraocular pressure following panretinal photocoagulation for diabetic retinopathy [Diabetic Retinopathy Study rep. no. 11]. Arch Ophthalmol 1987;105:807-809
17. Diabetic Retinopathy Study Group. Macular edema in Diabetic Retinopathy Study patients [Diabetic Retinopathy Study rep. no. 12]. Ophthalmology 1987;94:754-760
18. Diabetic Retinopathy Study Group. Factors associated with visual outcome after photocoagulation for diabetic retinopathy [Diabetic Retinopathy Study rep. no. 13]. Invest Ophthalmol Vis Sci 1989;30:23-28
19. Diabetic Retinopathy Study Group. Indications for photocoagulation treatment of diabetic retinopathy [Diabetic Retinopathy Study rep. no. 14]. Int Ophthalmol Clin 1987;27: 239-253
20. The Early Treatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema [Early Treatment Diabetic Retinopathy Study rep. no. 1]. Arch Ophthalmol 1985;103:1796-1806
21. The Early Treatment Diabetic Retinopathy Study Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema [Early Treatment Diabetic Retinopathy Study rep. no. 2]. Ophthalmology 1987;94:761-774
22. The Early Treatment Diabetic Retinopathy Study Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy [Early Treatment Diabetic Retinopathy Study rep. no. 3]. Int Ophthalmol Clin 1987;27:254-264
23. The Early Treatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema [Early Treatment Diabetic Retinopathy Study rep. no. 4]. Int Ophthalmol Clin 1987;27:265-272
24. The Early Treatment Diabetic Retinopathy Study Group. Case reports to accompany Early Treatment Diabetic Retinopathy Study reports 3 and 4 [Early Treatment Diabetic Retinopathy Study case rep. nos. 3 and 4]. Int Ophthalmol Clin 1987;27:273-333
25. The Early Treatment Diabetic Retinopathy Study Group. Detection of diabetic macular edema. Ophthalmoscopy versus photography [Early Treatment Diabetic Retinopathy Study rep. no. 5]. Ophthalmology 1989;96:746-751
26. The Early Treatment Diabetic Retinopathy Study Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics [Early Treatment Diabetic Retinopathy Study rep. no. 7]. Ophthalmology 1991;98:741-756
27. The Early Treatment Diabetic Retinopathy Study Group. Effects of aspirin treatment on diabetic retinopathy [Early Treatment Diabetic Retinopathy Study rep. no. 8]. Ophthalmology 1991;98:757-765
28. The Early Treatment Diabetic Retinopathy Study Group. Early photocoagulation for diabetic retinopathy [Early Treatment Diabetic Retinopathy Study rep. no. 9]. Ophthalmology 1991;98:766-785
29. The Early Treatment Diabetic Retinopathy Study Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification [Early Treatment Diabetic Retinopathy Study rep. no. 10]. Ophthalmology 1991;98:786-806
30. The Early Treatment Diabetic Retinopathy Study Group. Classification of diabetic retinopathy from fluorescein angiograms [Early Treatment Diabetic Retinopathy Study rep. no. 11]. Ophthalmology 1991;98:807-822
31. The Early Treatment Diabetic Retinopathy Study Group. Fundus photographic risk factors for progression of diabetic retinopathy [Early Treatment Diabetic Retinopathy Study rep. no. 12]. Ophthalmology 1991;98:823-833
32. The Early Treatment Diabetic Retinopathy Study Group. Fluorescein angiographic risk factors for progression of diabetic retinopathy [Early Treatment Diabetic Retinopathy Study rep. no. 13]. Ophthalmology 1991;98:834-840
33. The Diabetic Retinopathy Vitrectomy Study Group. Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management [Diabetic Retinopathy Vitrectomy Study rep. no. 1]. Ophthalmology 1985;92:492-502
34. The Diabetic Retinopathy Vitrectomy Study Group, Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial [Diabetic Retinopathy Vitrectomy Study rep. no. 2]. Arch Ophthalmol 1985;103:1644-1652
35. The Diabetic Retinopathy Vitrectomy Study Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial [Diabetic Retinopathy Vitrectomy Study rep. no. 3]. Ophthalmology 1988;95:1307-1320
36. The Diabetic Retinopathy Vitrectomy Study Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial [Diabetic Retinopathy Vitrectomy Study rep. no. 4]. Ophthalmology 1988;95:1321-1334
37. The Diabetic Retinopathy Vitrectomy Study Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial [Diabetic Retinopathy Vitrectomy Study rep. no. 5]. Arch Ophthalmol 1990;108:958-964
38. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 1986;35:530-545
39. The Diabetes Control and Complications Trial (DCCT). Results of feasibility study. Diabetes Care 1987;10:1-19
40. The Diabetes Control and Complications Trial (DCCT). Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? N Engl J Med 1988;318:246-250
41. The Diabetes Control and Complications Trial (DCCT). Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1987;105:1344-1351
42. The Diabetes Control and Complications Trial (DCCT). Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial. Diabetes 1988;37:476-481
43. Schumer M, Burton G, Burton C, et al. Diabetic autonomic neuropathy: Autonomic nervous system data analysis by a computerized central unit in a multicenter trial. Am J Med 1988;85:137-143
44. The Diabetes Control and Complications Trial (DCCTT). Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. Clin Chem 1987;33:2267-2271
45. The Diabetes Control and Complications Trial (DCCT). Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial. Diabetes Care 1988;11:725-732
46. The Diabetes Control and Complications Trial (DCCT). Update. Diabetes Care 1990;13: 427-433
47. The Diabetes Control and Complications Trial (DCCT). Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991;90:450-459
48. The Diabetes Control and Complications Trial (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
49. The Diabetes Control and Complications Trial (DCCT). The effect of intensive diabetes treatment on progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 1995;113:36-51
50. The Diabetes Control and Complications Trial (DCCT). Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995;102:647-661
51. Blankenship GW. Diabetic macular edema and laser photocoagulation. Ophthalmology 1979;86:69-75
52. British Multicenter Study Group. Photocoagulation for diabetic maculopathy: a randomized controlled clinical trial using xenon arc. Diabetes 1983;32:1010-1016
53. Marcus DG, Aaberg TM. Argon laser photocoagulation treatment in diabetic cystoid maculopathy. Ann Ophthalmol 1977;9:365-372
54. Machemer R, Parel JM, Buettner H. A new concept for vitreous surgery: I. Instrumentation. Am J Ophthalmol 1972;73:1-7
55. Machemer R. A new concept for vitreous surgery: II. Surgical technique and complications. Am J Ophthalmol 1972;74:1022-1033
56. Machemer R, Northon EWD. A new concept for vitreous surgery: III. Indications and results. Am J Ophthalmol 1972;74:1034-1056
57. Davis MD. Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 1965;74:741-751